Prostaglandin E 2 EP receptors as therapeutic targets in breast cancer

Cancer and Metastasis Reviews

Volumn 30, Issue 3-4, 2011, Pages 449-463

  Reader, Jocelyn ^a,b   Holt, Dawn ^b   Fulton, Amy ^a,b,c  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c Veterans Administration   (United States)

Author keywords

Cancer; Cyclooxygenase; EP receptors; Prostaglandin

Indexed keywords

CELL SURFACE RECEPTOR; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; G PROTEIN COUPLED RECEPTOR; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN D2; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; ANTINEOPLASTIC AGENT; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER INCIDENCE; CANCER SURVIVAL; CARCINOGENESIS; CELL MEMBRANE; ENZYME ACTIVITY; EPITHELIUM CELL; HUMAN; ICOSANOID METABOLISM; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOREACTIVITY; METASTASIS; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; BREAST TUMOR; DRUG ANTAGONISM; FEMALE; METABOLISM; REVIEW;

ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; FEMALE; HUMANS; IMMUNE SYSTEM; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RECEPTORS, PROSTAGLANDIN E;

EID: 83855165720     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/s10555-011-9303-2     Document Type: Article

References (153)

1. DF Legler M Bruckner E Uetz-von Allmen P Krause 2010 Prostaglandin E2 at new glance: novel insights in functional diversity offer therapeutic chances The International Journal of Biochemistry & Cell Biology 42 2 198 201 1:CAS:528:DC%2BC3cXnsFarsA%3D%3D
2. M-T Wang KV Honn D Nie 2007 Cyclooxygenases, prostanoids, and tumor progression Cancer and Metastasis Reviews 26 3-4 525 534 17763971 1:CAS:528:DC%2BD2sXht1yktLbP
3. Y Sugimoto S Narumiya 2007 Prostaglandin E receptors Journal of Biological Chemistry 282 16 11613 11617 17329241 1:CAS:528:DC%2BD2sXktFemtbs%3D
4. AJ Dannenberg K Subbaramaiah 2003 Targeting cyclooxygenase-2 in human neoplasia: rationale and promise Cancer Cell 4 6 431 436 14706335 1:CAS:528:DC%2BD2cXitFKquw%3D%3D
5. N Kundu Q Yang R Dorsey AM Fulton 2001 Increased cyclooxygenase-2 (cox-2) expression and activity in a murine model of metastatic breast cancer International Journal of Cancer 93 5 681 686 1:CAS:528:DC%2BD3MXls1Wgtrk%3D
6. A Greenhough HJM Smartt AE Moore HR Roberts AC Williams C Paraskeva, et al. 2009 The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment Carcinogenesis 30 3 377 386 19136477 1:CAS:528:DC%2BD1MXivFSiuro%3D
7. DG Menter RL Schilsky RN DuBois 2010 Cyclooxygenase-2 and cancer treatment: understanding the risk should be worth the reward Clinical Cancer Research 16 5 1384 1390 20179228 1:CAS:528:DC%2BC3cXisFSisrs%3D
8. D Wang RN Dubois 2010 Eicosanoids and cancer Nature Reviews. Cancer 10 3 181 193 20168319 1:CAS:528:DC%2BC3cXitFemsbs%3D
9. M Nakanishi V Gokhale EJ Meuillet DW Rosenberg 2010 mPGES-1 as a target for cancer suppression: a comprehensive invited review "Phospholipase A2 and lipid mediators" Biochimie 92 6 660 664 20159031 1:CAS:528: DC%2BC3cXmslGhtb8%3D
10. AJ Schetter NHH Heegaard CC Harris 2010 Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways Carcinogenesis 31 1 37 49 19955394 1:CAS:528:DC%2BC3cXktlCmug%3D%3D
11. LR Howe 2007 Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer Breast Cancer Research 9 4 210 17640394
12. LR Howe AJ Dannenberg 2003 COX-2 inhibitors for the prevention of breast cancer Journal of Mammary Gland Biology and Neoplasia 8 1 31 43 14587862
13. A Ristimäki A Sivula J Lundin M Lundin T Salminen C Haglund, et al. 2002 Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer Cancer Research 62 3 632 635 11830510
14. B Singh JA Berry A Shoher GD Ayers C Wei A Lucci 2007 COX-2 involvement in breast cancer metastasis to bone Oncogene 26 26 3789 3796 17213821 1:CAS:528:DC%2BD2sXlvFaksr0%3D
15. CH Liu SH Chang K Narko OC Trifan MT Wu E Smith, et al. 2001 Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice Journal of Biological Chemistry 276 21 18563 18569 11278747 1:CAS:528:DC%2BD3MXktFWmtbc%3D
16. MP Zerkowski RL Camp BA Burtness DL Rimm GG Chung 2007 Quantitative analysis of breast cancer tissue microarrays shows high cox-2 expression is associated with poor outcome Cancer Investigation 25 1 19 26 17364553 1:CAS:528:DC%2BD2sXnt1agsLw%3D
17. BYS Chuah T Putti M Salto-Tellez A Charlton P Iau SA Buhari, et al. 2011 Serial changes in the expression of breast cancer-related proteins in response to neoadjuvant chemotherapy Annals of Oncology 22 8 1748 1754 21355070 1:STN:280:DC%2BC3MjhsFOrsQ%3D%3D
18. GS Ranger V Thomas A Jewell K Mokbel 2004 Elevated cyclooxygenase-2 expression correlates with distant metastases in breast cancer Anticancer Research 24 4 2349 2351 15330183 1:CAS:528:DC%2BD2cXot1Cgu74%3D
19. X Ma Q Yang KT Wilson N Kundu SJ Meltzer AM Fulton 2004 Promoter methylation regulates cyclooxygenase expression in breast cancer Breast Cancer Research 6 4 R316 321 15217498 1:CAS:528:DC%2BD2cXkvVGhtLY%3D
20. N Kundu AM Fulton 2002 Selective cyclooxygenase (COX)-1 or COX-2 inhibitors control metastatic disease in a murine model of breast cancer Cancer Research 62 8 2343 2346 11956094 1:CAS:528:DC%2BD38Xjt1ejurw%3D
21. AJ Minn GP Gupta PM Siegel PD Bos W Shu DD Giri, et al. 2005 Genes that mediate breast cancer metastasis to lung Nature 436 7050 518 524 16049480 1:CAS:528:DC%2BD2MXmsFCgs7o%3D
22. PD Bos XH-F Zhang C Nadal W Shu RR Gomis DX Nguyen, et al. 2009 Genes that mediate breast cancer metastasis to the brain Nature 459 7249 1005 1009 19421193 1:CAS:528:DC%2BD1MXlsVKksLc%3D
23. B Singh JA Berry A Shoher V Ramakrishnan A Lucci 2005 COX-2 overexpression increases motility and invasion of breast cancer cells International Journal of Oncology 26 5 1393 1399 15809733 1:CAS:528: DC%2BD2MXktVOrtr4%3D
24. I Stasinopoulos DR O'Brien F Wildes K Glunde ZM Bhujwalla 2007 Silencing of cyclooxygenase-2 inhibits metastasis and delays tumor onset of poorly differentiated metastatic breast cancer cells Molecular Cancer Research 5 5 435 442 17510310 1:CAS:528:DC%2BD2sXmtVOju7Y%3D
25. ER Greenberg JA Baron DH Freeman Jr JS Mandel R Haile 1993 Reduced risk of large-bowel adenomas among aspirin users. The Polyp Prevention Study Group Journal of the National Cancer Institute 85 11 912 916 8492320 1:STN:280:DyaK3s3mtVOhug%3D%3D
26. RF Logan J Little PG Hawtin JD Hardcastle 1993 Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme BMJ 307 6899 285 289 8374373 1:STN:280:DyaK3szosF2jtQ%3D%3D
27. MJ Reeves PA Newcomb A Trentham-Dietz BE Storer PL Remington 1996 Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women Cancer Epidemiology, Biomarkers & Prevention 5 12 955 960 1:CAS:528:DyaK2sXlvFGjuw%3D%3D
28. MJ Thun MM Namboodiri CW Heath Jr 1991 Aspirin use and reduced risk of fatal colon cancer The New England Journal of Medicine 325 23 1593 1596 1669840 1:STN:280:DyaK38%2FkvFGqtw%3D%3D
29. CE Eberhart RJ Coffey A Radhika FM Giardiello S Ferrenbach RN DuBois 1994 Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas Gastroenterology 107 4 1183 1188 7926468 1:STN:280:DyaK2M%2FhtFamsA%3D%3D
30. SL Kargman GP O'Neill PJ Vickers JF Evans JA Mancini S Jothy 1995 Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer Cancer Research 55 12 2556 2559 7780968 1:CAS:528:DyaK2MXmtlWrsbk%3D
31. H Sano Y Kawahito RL Wilder A Hashiramoto S Mukai K Asai, et al. 1995 Expression of cyclooxygenase-1 and -2 in human colorectal cancer Cancer Research 55 17 3785 3789 7641194 1:CAS:528:DyaK2MXnvVelsbg%3D
32. W Kutchera DA Jones N Matsunami J Groden TM McIntyre GA Zimmerman, et al. 1996 Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect Proceedings of the National Academy of Sciences of the United States of America 93 10 4816 4820 8643486 1:CAS:528:DyaK28XjtVKlsbw%3D
33. LR Howe K Subbaramaiah AM Brown AJ Dannenberg 2001 Cyclooxygenase-2: a target for the prevention and treatment of breast cancer Endocrine-Related Cancer 8 2 97 114 11397667 1:CAS:528:DC%2BD3MXls1KqtbY%3D
34. TL Larkins M Nowell S Singh GL Sanford 2006 Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression BMC Cancer 6 181 16831226
35. EM Connolly JH Harmey T O'Grady D Foley G Roche-Nagle E Kay, et al. 2002 Cyclo-oxygenase inhibition reduces tumour growth and metastasis in an orthotopic model of breast cancer British Journal of Cancer 87 2 231 237 12107848 1:CAS:528:DC%2BD38XltFeksb4%3D
36. GD Friedman HK Ury 1980 Initial screening for carcinogenicity of commonly used drugs Journal of the National Cancer Institute 65 4 723 733 6932525 1:STN:280:DyaL3M%2FivVOhtg%3D%3D
37. RE Harris RT Chlebowski RD Jackson DJ Frid JL Ascenseo G Anderson, et al. 2003 Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative Cancer Research 63 18 6096 6101 14522941 1:CAS:528:DC%2BD3sXnvVSitb8%3D
38. RE Harris KK Namboodiri WB Farrar 1996 Nonsteroidal antiinflammatory drugs and breast cancer Epidemiology 7 2 203 205 8834563 1:STN:280: DyaK28vjtFCrsw%3D%3D
39. RE Harris J Beebe-Donk GA Alshafie 2006 Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors BMC Cancer 6 27 16445867
40. E Rahme J Ghosn K Dasgupta R Rajan M Hudson 2005 Association between frequent use of nonsteroidal anti-inflammatory drugs and breast cancer BMC Cancer 5 159 16343343
41. MD Holmes WY Chen L Li E Hertzmark D Spiegelman SE Hankinson 2010 Aspirin intake and survival after breast cancer Journal of Clinical Oncology 28 9 1467 1472 20159825 1:CAS:528:DC%2BC3cXltFGhsLw%3D
42. A Ready CM Velicer A McTiernan E White 2008 NSAID use and breast cancer risk in the VITAL cohort Breast Cancer Research and Treatment 109 3 533 543 17674199 1:CAS:528:DC%2BD1cXlvVCgtrY%3D
43. SA Khuder AB Mutgi 2001 Breast cancer and NSAID use: a meta-analysis British Journal of Cancer 84 9 1188 1192 11336469 1:CAS:528:DC%2BD3MXkt1Olurc%3D
44. C Bosetti S Gallus C La Vecchia 2006 Aspirin and cancer risk: an updated quantitative review to 2005 Cancer Causes & Control 17 7 871 888
45. S Mangiapane M Blettner P Schlattmann 2008 Aspirin use and breast cancer risk: a meta-analysis and meta-regression of observational studies from 2001 to 2005 Pharmacoepidemiology and Drug Safety 17 2 115 124 17955496
46. B Takkouche C Regueira-Méndez M Etminan 2008 Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis Journal of the National Cancer Institute 100 20 1439 1447 18840819 1:CAS:528:DC%2BD1cXht1Oisb7I
47. ME Valsecchi SC Pomerantz R Jaslow W Tester 2009 Reduced risk of bone metastasis for patients with breast cancer who use COX-2 inhibitors Clinical Breast Cancer 9 4 225 230 19933077 1:CAS:528:DC%2BD1MXhsF2iu73N
48. JK Gill G Maskarinec LR Wilkens MC Pike BE Henderson LN Kolonel 2007 Nonsteroidal antiinflammatory drugs and breast cancer risk: the multiethnic cohort American Journal of Epidemiology 166 10 1150 1158 17698973
49. GL Gierach JV Lacey Jr A Schatzkin MF Leitzmann D Richesson AR Hollenbeck, et al. 2008 Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study Breast Cancer Research 10 2 R38 18447943
50. SM Zhang NR Cook JE Manson I-M Lee JE Buring 2008 Low-dose aspirin and breast cancer risk: results by tumour characteristics from a randomised trial British Journal of Cancer 98 5 989 991 18268496 1:CAS:528:DC%2BD1cXivVOgt7g%3D
51. EJ Jacobs MJ Thun EB Bain C Rodriguez SJ Henley EE Calle 2007 A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence Journal of the National Cancer Institute 99 8 608 615 17440162 1:CAS:528:DC%2BD2sXlvVSksbY%3D
52. RS Bresalier RS Sandler H Quan JA Bolognese B Oxenius K Horgan, et al. 2005 Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial The New England Journal of Medicine 352 11 1092 1102 15713943 1:CAS:528:DC%2BD2MXit1Kqu7o%3D
53. SD Solomon JJV McMurray MA Pfeffer J Wittes R Fowler P Finn, et al. 2005 Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention The New England Journal of Medicine 352 11 1071 1080 15713944 1:CAS:528:DC%2BD2MXit1Kqur4%3D
54. T Grosser S Fries GA FitzGerald 2006 Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities The Journal of Clinical Investigation 116 1 4 15 16395396 1:CAS:528:DC%2BD28XjslOjtQ%3D%3D
55. WM Oldham HE Hamm 2008 Heterotrimeric G protein activation by G-protein-coupled receptors Nature Reviews Molecular Cell Biology 9 1 60 71 18043707 1:CAS:528:DC%2BD2sXhsVKrsrrO
56. R Lappano M Maggiolini 2011 G protein-coupled receptors: novel targets for drug discovery in cancer Nature Reviews. Drug Discovery 10 1 47 60 21193867 1:CAS:528:DC%2BC3MXjvFCl
57. AM Fulton X Ma N Kundu 2006 Targeting prostaglandin E EP receptors to inhibit metastasis Cancer Research 66 20 9794 9797 17047037 1:CAS:528: DC%2BD28XhtVyiurzJ
58. A Ichikawa Y Sugimoto S Tanaka 2010 Molecular biology of histidine decarboxylase and prostaglandin receptors Proceedings of the Japan Academy. Series B, Physical and Biological Sciences 86 8 848 866 20948178 1:CAS:528:DC%2BC3cXhsFOntrzK
59. JW Regan 2003 EP2 and EP4 prostanoid receptor signaling Life Sciences 74 2-3 143 153 14607241 1:CAS:528:DC%2BD3sXos12qtro%3D
60. I Dey M Lejeune K Chadee 2006 Prostaglandin E2 receptor distribution and function in the gastrointestinal tract British Journal of Pharmacology 149 6 611 623 17016496 1:CAS:528:DC%2BD28XhtF2jsbrF
61. H Fujino JW Regan 2006 EP(4) prostanoid receptor coupling to a pertussis toxin-sensitive inhibitory G protein Molecular Pharmacology 69 1 5 10 16204467 1:CAS:528:DC%2BD28XktlWhtg%3D%3D
62. H Katoh A Watabe Y Sugimoto A Ichikawa M Negishi 1995 Characterization of the signal transduction of prostaglandin E receptor EP1 subtype in cDNA-transfected Chinese hamster ovary cells Biochimica et Biophysica Acta 1244 1 41 48 7766667
63. H Tabata S Tanaka Y Sugimoto H Kanki S Kaneko A Ichikawa 2002 Possible coupling of prostaglandin E receptor EP(1) to TRP5 expressed in Xenopus laevis oocytes Biochemical and Biophysical Research Communications 298 3 398 402 12413954 1:CAS:528:DC%2BD38XotFSgur0%3D
64. R Ji C-L Chou W Xu X-B Chen DF Woodward JW Regan 2010 EP1 prostanoid receptor coupling to G i/o up-regulates the expression of hypoxia-inducible factor-1 alpha through activation of a phosphoinositide-3 kinase signaling pathway Molecular Pharmacology 77 6 1025 1036 20335389 1:CAS:528: DC%2BC3cXmslKnt78%3D
65. B Voss JN McLaughlin M Holinstat R Zent HE Hamm 2007 PAR1, but not PAR4, activates human platelets through a Gi/o/phosphoinositide-3 kinase signaling axis Molecular Pharmacology 71 5 1399 1406 17303701 1:CAS:528: DC%2BD2sXlslSis7s%3D
66. E Okuda-Ashitaka K Sakamoto T Ezashi K Miwa S Ito O Hayaishi 1996 Suppression of prostaglandin E receptor signaling by the variant form of EP1 subtype Journal of Biological Chemistry 271 49 31255 31261 8940129 1:CAS:528:DyaK28Xns1ajtrY%3D
67. K Gomi FG Zhu JS Marshall 2000 Prostaglandin E2 selectively enhances the IgE-mediated production of IL-6 and granulocyte-macrophage colony-stimulating factor by mast cells through an EP1/EP3-dependent mechanism Journal of Immunology 165 11 6545 6552 1:CAS:528:DC%2BD3cXosFOhsbw%3D
68. L Kotelevets N Foudi L Louedec A Couvelard E Chastre X Norel 2007 A new mRNA splice variant coding for the human EP3-I receptor isoform Prostaglandins, Leukotrienes, and Essential Fatty Acids 77 3-4 195 201 18023986 1:CAS:528:DC%2BD2sXhtlGgsL%2FF
69. DD Israel JW Regan 2009 EP(3) prostanoid receptor isoforms utilize distinct mechanisms to regulate ERK 1/2 activation Biochimica et Biophysica Acta 1791 4 238 245 19416642 1:CAS:528:DC%2BD1MXjsVOju7Y%3D
70. M Kotani I Tanaka Y Ogawa T Usui K Mori A Ichikawa, et al. 1995 Molecular cloning and expression of multiple isoforms of human prostaglandin E receptor EP3 subtype generated by alternative messenger RNA splicing: multiple second messenger systems and tissue-specific distributions Molecular Pharmacology 48 5 869 879 7476918 1:CAS:528:DyaK2MXps1amtr8%3D
71. HA Bilson DL Mitchell B Ashby 2004 Human prostaglandin EP3 receptor isoforms show different agonist-induced internalization patterns FEBS Letters 572 1-3 271 275 15304361 1:CAS:528:DC%2BD2cXmsVGht7g%3D
72. J Jin GF Mao B Ashby 1997 Constitutive activity of human prostaglandin E receptor EP3 isoforms British Journal of Pharmacology 121 2 317 323 9154343 1:CAS:528:DyaK2sXjtFyltr8%3D
73. RM Breyer CK Bagdassarian SA Myers MD Breyer 2001 Prostanoid receptors: subtypes and signaling Annual Review of Pharmacology and Toxicology 41 661 690 11264472 1:CAS:528:DC%2BD3MXjsVaqt7g%3D
74. S An J Yang SW So L Zeng EJ Goetzl 1994 Isoforms of the EP3 subtype of human prostaglandin E2 receptor transduce both intracellular calcium and cAMP signals Biochemistry 33 48 14496 14502 7981210 1:CAS:528:DyaK2cXmvFaqtLY%3D
75. A Schmid KH Thierauch WD Schleuning H Dinter 1995 Splice variants of the human EP3 receptor for prostaglandin E2 European Journal of Biochemistry 228 1 23 30 7883006 1:CAS:528:DyaK2MXjvFKks70%3D
76. N Hatae Y Sugimoto A Ichikawa 2002 Prostaglandin receptors: advances in the study of EP3 receptor signaling Journal of Biochemistry 131 6 781 784 12038972 1:CAS:528:DC%2BD38XlslKktL0%3D
77. Y Sugimoto M Negishi Y Hayashi T Namba A Honda A Watabe, et al. 1993 Two isoforms of the EP3 receptor with different carboxyl-terminal domains. Identical ligand binding properties and different coupling properties with Gi proteins Journal of Biological Chemistry 268 4 2712 2718 8381413 1:CAS:528: DyaK3sXkt1Slt70%3D
78. A Irie Y Sugimoto T Namba A Harazono A Honda A Watabe, et al. 1993 Third isoform of the prostaglandin-E-receptor EP3 subtype with different C-terminal tail coupling to both stimulation and inhibition of adenylate cyclase European Journal of Biochemistry 217 1 313 318 8223569 1:CAS:528:DyaK3sXlvFGqsL8%3D
79. K Yamaoka A Yano K Kuroiwa K Morimoto T Inazumi N Hatae, et al. 2009 Prostaglandin EP3 receptor superactivates adenylyl cyclase via the Gq/PLC/Ca2+ pathway in a lipid raft-dependent manner Biochemical and Biophysical Research Communications 389 4 678 682 19769944 1:CAS:528:DC%2BD1MXht1Gmt7jM
80. N Hatae K Yamaoka Y Sugimoto M Negishi A Ichikawa 2002 Augmentation of receptor-mediated adenylyl cyclase activity by Gi-coupled prostaglandin receptor subtype EP3 in a Gbetagamma subunit-independent manner Biochemical and Biophysical Research Communications 290 1 162 168 11779148 1:CAS:528: DC%2BD38XhsFCitw%3D%3D
81. A Irie E Segi Y Sugimoto A Ichikawa M Negishi 1994 Mouse prostaglandin E receptor EP3 subtype mediates calcium signals via Gi in cDNA-transfected Chinese hamster ovary cells Biochemical and Biophysical Research Communications 204 1 303 309 7945376 1:CAS:528:DyaK2cXmsVOjtrk%3D
82. T Zhu F Gobeil A Vazquez-Tello M Leduc L Rihakova M Bossolasco, et al. 2006 Intracrine signaling through lipid mediators and their cognate nuclear G-protein-coupled receptors: a paradigm based on PGE2, PAF, and LPA1 receptors Canadian Journal of Physiology and Pharmacology 84 3-4 377 391 16902584 1:CAS:528:DC%2BD28XnsVOlurw%3D
83. F Gobeil A Fortier T Zhu M Bossolasco M Leduc M Grandbois, et al. 2006 G-protein-coupled receptors signalling at the cell nucleus: an emerging paradigm Canadian Journal of Physiology and Pharmacology 84 3-4 287 297 16902576 1:CAS:528:DC%2BD28XnsVOltLc%3D
84. F Gobeil Jr A Vazquez-Tello AM Marrache M Bhattacharya D Checchin G Bkaily, et al. 2003 Nuclear prostaglandin signaling system: biogenesis and actions via heptahelical receptors Canadian Journal of Physiology and Pharmacology 81 2 196 204 12710534 1:CAS:528:DC%2BD3sXisVCgsbs%3D
85. F Gobeil Jr I Dumont AM Marrache A Vazquez-Tello SG Bernier D Abran, et al. 2002 Regulation of eNOS expression in brain endothelial cells by perinuclear EP(3) receptors Circulation Research 90 6 682 689 11934836 1:CAS:528: DC%2BD38XjtF2gt7w%3D
86. M Bhattacharya K Peri A Ribeiro-da-Silva G Almazan H Shichi X Hou, et al. 1999 Localization of functional prostaglandin E2 receptors EP3 and EP4 in the nuclear envelope Journal of Biological Chemistry 274 22 15719 15724 10336471 1:CAS:528:DyaK1MXjsV2gt70%3D
87. M Bhattacharya KG Peri G Almazan A Ribeiro-da-Silva H Shichi Y Durocher, et al. 1998 Nuclear localization of prostaglandin E2 receptors Proceedings of the National Academy of Sciences of the United States of America 95 26 15792 15797 9861049 1:CAS:528:DyaK1MXhvFeguw%3D%3D
88. MA Thorat A Morimiya S Mehrotra R Konger SS Badve 2008 Prostanoid receptor EP1 expression in breast cancer Modern Pathology 21 1 15 21 17906615 1:CAS:528:DC%2BD1cXhtFCkug%3D%3D
89. X Ma N Kundu OB Ioffe O Goloubeva R Konger C Baquet, et al. 2010 Prostaglandin E receptor EP1 suppresses breast cancer metastasis and is linked to survival differences and cancer disparities Molecular Cancer Research 8 10 1310 1318 20858737 1:CAS:528:DC%2BC3cXht12ksLnN
90. C Han AJ Demetris DB Stolz L Xu K Lim T Wu 2006 Modulation of Stat3 activation by the cytosolic phospholipase A2alpha and cyclooxygenase-2- controlled prostaglandin E2 signaling pathway Journal of Biological Chemistry 281 34 24831 24846 16790433 1:CAS:528:DC%2BD28Xot1eqtbs%3D
91. PH Rolland PM Martin J Jacquemier AM Rolland M Toga 1980 Prostaglandin in human breast cancer: evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells Journal of the National Cancer Institute 64 5 1061 1070 6767871 1:CAS:528: DyaL3cXktVGmurY%3D
92. A Bennett EM Charlier AM McDonald JS Simpson IF Stamford T Zebro 1977 Prostaglandins and breast cancer Lancet 2 8039 624 626 71446 1:STN:280:DyaE1c%2FgvFaluw%3D%3D
93. WC Tan OS Privett ME Goldyne 1974 Studies of prostaglandins in rat mammary tumors induced by 7,12-dimethylbenz(a)anthracene Cancer Research 34 12 3229 3231 4429952 1:CAS:528:DyaE2MXkslKksL0%3D
94. S-H Chang CH Liu R Conway DK Han K Nithipatikom OC Trifan, et al. 2004 Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression Proceedings of the National Academy of Sciences of the United States of America 101 2 591 596 14688410 1:CAS:528: DC%2BD2cXmsFGmsw%3D%3D
95. S-H Chang Y Ai RM Breyer TF Lane T Hla 2005 The prostaglandin E2 receptor EP2 is required for cyclooxygenase 2-mediated mammary hyperplasia Cancer Research 65 11 4496 4499 15930264 1:CAS:528:DC%2BD2MXks1Oht74%3D
96. S-H Chang CH Liu M-T Wu T Hla 2005 Regulation of vascular endothelial cell growth factor expression in mouse mammary tumor cells by the EP2 subtype of the prostaglandin E2 receptor Prostaglandins & Other Lipid Mediators 76 1-4 48 58 1:CAS:528:DC%2BD2MXks1arsb4%3D
97. M Tian WP Schiemann 2010 PGE2 receptor EP2 mediates the antagonistic effect of COX-2 on TGF-beta signaling during mammary tumorigenesis The FASEB Journal 24 4 1105 1116 19897661 1:CAS:528:DC%2BC3cXktlOqsbw%3D
98. K Subbaramaiah C Hudis SH Chang T Hla AJ Dannenberg 2008 EP2 and EP4 receptors regulate aromatase expression in human adipocytes and breast cancer cells. Evidence of a BRCA1 and p300 exchange Journal of Biological Chemistry 283 6 3433 3444 18083712 1:CAS:528:DC%2BD1cXhtlyis7k%3D
99. JA Richards RW Brueggemeier 2003 Prostaglandin E2 regulates aromatase activity and expression in human adipose stromal cells via two distinct receptor subtypes Journal of Clinical Endocrinology and Metabolism 88 6 2810 2816 12788892 1:CAS:528:DC%2BD3sXkslCrsb4%3D
100. Y Zhao VR Agarwal CR Mendelson ER Simpson 1996 Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene Endocrinology 137 12 5739 5742 8940410 1:CAS:528:DyaK28Xnt1Kju7w%3D
101. EH Han HG Kim YP Hwang JH Choi JH Im B Park, et al. 2010 The role of cyclooxygenase-2-dependent signaling via cyclic AMP response element activation on aromatase up-regulation by o,p′-DDT in human breast cancer cells Toxicology Letters 198 3 331 341 20678559 1:CAS:528:DC%2BC3cXhtFGhurrN
102. K Subbaramaiah LR Howe P Bhardwaj B Du C Gravaghi RK Yantiss, et al. 2011 Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland Cancer Prevention Research (Philadelphia, Pa.) 4 3 329 346 1:CAS:528:DC%2BC3MXktl2ltb0%3D
103. FM Robertson A-M Simeone A Mazumdar AH Shah JS McMurray S Ghosh, et al. 2008 Molecular and pharmacological blockade of the EP4 receptor selectively inhibits both proliferation and invasion of human inflammatory breast cancer cells Journal of Experimental Therapeutics and Oncology 7 4 299 312 19227010 1:CAS:528:DC%2BD1MXitlWltbw%3D
104. FM Robertson A-M Simeone A Lucci JS McMurray S Ghosh M Cristofanilli 2010 Differential regulation of the aggressive phenotype of inflammatory breast cancer cells by prostanoid receptors EP3 and EP4 Cancer 116 11 Suppl 2806 2814 20503412 1:CAS:528:DC%2BC3cXnvVagsr4%3D
105. R Blindt A-K Bosserhoff J vom Dahl P Hanrath K Schrör T Hohlfeld, et al. 2002 Activation of IP and EP(3) receptors alters cAMP-dependent cell migration European Journal of Pharmacology 444 1-2 31 37 12191579 1:CAS:528:DC%2BD38XksVSitb0%3D
106. H Amano I Hayashi H Endo H Kitasato S Yamashina T Maruyama, et al. 2003 Host prostaglandin E(2)-EP3 signaling regulates tumor-associated angiogenesis and tumor growth The Journal of Experimental Medicine 197 2 221 232 12538661 1:CAS:528:DC%2BD3sXmt1Sjuw%3D%3D
107. T Taniguchi H Fujino DD Israel JW Regan T Murayama 2008 Human EP3(I) prostanoid receptor induces VEGF and VEGF receptor-1 mRNA expression Biochemical and Biophysical Research Communications 377 4 1173 1178 18996083 1:CAS:528:DC%2BD1cXhsVGhu7rO
108. H Kubo K Hosono T Suzuki Y Ogawa H Kato H Kamata, et al. 2010 Host prostaglandin EP3 receptor signaling relevant to tumor-associated lymphangiogenesis Biomedicine and Pharmacotherapy 64 2 101 106 1:CAS:528:DC%2BC3cXit1GkurY%3D
109. AV Timoshenko C Chakraborty GF Wagner PK Lala 2006 COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer British Journal of Cancer 94 8 1154 1163 16570043 1:CAS:528:DC%2BD28XjsFaksLw%3D
110. KL Tober TA Wilgus DF Kusewitt JM Thomas-Ahner T Maruyama TM Oberyszyn 2006 Importance of the EP(1) receptor in cutaneous UVB-induced inflammation and tumor development The Journal of Investigative Dermatology 126 1 205 211 16417238 1:CAS:528:DC%2BD28Xlt1Wisr0%3D
111. X-M Bai H Jiang J-X Ding T Peng J Ma Y-H Wang, et al. 2010 Prostaglandin E2 upregulates survivin expression via the EP1 receptor in hepatocellular carcinoma cells Life Sciences 86 5-6 214 223 20035770 1:CAS:528: DC%2BC3cXhtVKitr0%3D
112. T Kawamori N Uchiya S Nakatsugi K Watanabe S Ohuchida H Yamamoto, et al. 2001 Chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP(1) antagonist, on breast cancer development Carcinogenesis 22 12 2001 2004 11751431 1:CAS:528:DC%2BD38Xos1Sntg%3D%3D
113. 2)/EP4 receptor signaling pathway in colon cancer cells Cancer Biology & Therapy 10 10 1056 1066 1:CAS:528:DC%2BC3MXit1egsrk%3D
114. DP Cherukuri XBO Chen A-C Goulet RN Young Y Han RL Heimark, et al. 2007 The EP4 receptor antagonist, L-161,982, blocks prostaglandin E2-induced signal transduction and cell proliferation in HCA-7 colon cancer cells Experimental Cell Research 313 14 2969 2979 17631291 1:CAS:528:DC%2BD2sXosFyktLo%3D
115. L Yang Y Huang R Porta K Yanagisawa A Gonzalez E Segi, et al. 2006 Host and direct antitumor effects and profound reduction in tumor metastasis with selective EP4 receptor antagonism Cancer Research 66 19 9665 9672 17018624 1:CAS:528:DC%2BD28XhtVams73P
116. H Oshima BK Popivanova K Oguma D Kong TO Ishikawa M Oshima 2011 Activation of epidermal growth factor receptor signaling by the prostaglandin E(2) receptor EP4 pathway during gastric tumorigenesis Cancer Science 102 4 713 719 21205091 1:CAS:528:DC%2BC3MXltFGjsbY%3D
117. N Terada Y Shimizu T Kamba T Inoue A Maeno T Kobayashi, et al. 2010 Identification of EP4 as a potential target for the treatment of castration-resistant prostate cancer using a novel xenograft model Cancer Research 70 4 1606 1615 20145136 1:CAS:528:DC%2BC3cXhvFaksbc%3D
118. Y Zheng JD Ritzenthaler X Sun J Roman S Han 2009 Prostaglandin E2 stimulates human lung carcinoma cell growth through induction of integrin-linked kinase: the involvement of EP4 and Sp1 Cancer Research 69 3 896 904 19176380 1:CAS:528:DC%2BD1MXhtFOktLs%3D
119. JI Kim V Lakshmikanthan N Frilot Y Daaka 2010 Prostaglandin E2 promotes lung cancer cell migration via EP4-βArrestin1-c-Src signalsome Molecular Cancer Research 8 4 569 577 20353998 1:CAS:528:DC%2BC3cXkslSrurw%3D
120. A Timoshenko X Guoxiong S CHakrabarti P Lala C Chakraborty 2003 Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells Experimental Cell Research 289 265 274 14499627 1:CAS:528:DC%2BD3sXnt1Ggtb4%3D
121. AV Timoshenko PK Lala C Chakraborty 2004 PGE2-mediated upregulation of iNOS in murine breast cancer cells through the activation of EP4 receptors International Journal of Cancer 108 3 384 389 1:CAS:528:DC%2BD3sXhtVSlsr7M
122. LC Jadeski C Chakraborty PK Lala 2002 Role of nitric oxide in tumour progression with special reference to a murine breast cancer model Canadian Journal of Physiology and Pharmacology 80 2 125 135 11934255 1:CAS:528:DC%2BD38XisVKntrg%3D
123. T Ohshiba C Miyaura A Ito 2003 Role of prostaglandin E produced by osteoblasts in osteolysis due to bone metastasis Biochemical and Biophysical Research Communications 300 4 957 964 12559967 1:CAS:528:DC%2BD3sXmsVCmsA%3D%3D
124. M-R Pan M-F Hou H-C Chang W-C Hung 2008 Cyclooxygenase-2 up-regulates CCR7 via EP2/EP4 receptor signaling pathways to enhance lymphatic invasion of breast cancer cells Journal of Biological Chemistry 283 17 11155 11163 18319253 1:CAS:528:DC%2BD1cXkvVSgsL8%3D
125. K Subbaramaiah R Benezra C Hudis AJ Dannenberg 2008 Cyclooxygenase-2- derived prostaglandin E2 stimulates Id-1 transcription Journal of Biological Chemistry 283 49 33955 33968 18842581 1:CAS:528:DC%2BD1cXhsVelu7%2FJ
126. X Ma N Kundu S Rifat T Walser AM Fulton 2006 Prostaglandin E receptor EP4 antagonism inhibits breast cancer metastasis Cancer Research 66 6 2923 2927 16540639 1:CAS:528:DC%2BD28XitlersL4%3D
127. N Kundu X Ma D Holt O Goloubeva S Ostrand-Rosenberg AM Fulton 2009 Antagonism of the prostaglandin E receptor EP4 inhibits metastasis and enhances NK function Breast Cancer Research and Treatment 117 2 235 242 18792778 1:CAS:528:DC%2BD1MXpvF2gsLw%3D
128. M Choudhry Z Ahmed M Sayeed 1999 PGE(2)-mediated inhibition of T-cell p59 (fyn) is independent of cAMP American Journal of Physiology 277 2Pt1 C301 C309
129. S Harris J Padilla L Koumas D Ray R Phipps 2002 Prostaglandins as modulators of immunity Trends in Immunology 23 3 144 150 11864843 1:CAS:528:DC%2BD38XhsFaht7w%3D
130. M Choudhry P Hockberger M Sayeed 1999 PGE2 suppresses mitogen-induced Ca2+ mobilization in T cells American Journal of Physiology 277 6Pt2 R17410 R1748
131. B Porter T Malek 1999 Prostaglandin E2 inhibits T-cell activation-induced apoptosis and Fas-mediated cellular cytotoxicity by blockade of Fas-ligand induction European Journal of Immunology 29 7 2360 2365 10427999 1:CAS:528:DyaK1MXksFCrtr0%3D
132. C Hilkens A Snijders F Snijdewint E Wierenga M Kapsenberg 1996 Modulation of T-cell cytokine secretion by accessory-cell-derived products European Respiratory Journal Supplement 22 90s 94s 1:STN:280:DyaK2s%2FisVyhtQ%3D%3D
133. P Garrone L Galibert F Rousset S Fu J Branchereau 1994 Regulatory effects of prostaglandin E2 on the growth and differentiation of human B lymphocytes activated through their CD40 antigen Journal of Immunology 152 9 4282 4290 1:CAS:528:DyaK2cXjt1Wgsrw%3D
134. D Brown G Warner S Ales-Marinez D Scott R Phipps 1992 Prostaglandin E2 induces apoptosis in immature normal and malignant B lymphocytes Clinical Immunology and Immunopathology 63 3 221 229 1623642 1:CAS:528:DyaK38Xks1eltrk%3D
135. R Roper D Brown R Phipps 1995 Prostaglandin E2 promotes B lymphocyte Ig isotype switching to IgE The Journal of Immunology 154 162 170 7995935 1:CAS:528:DyaK2MXivVShu7o%3D
136. R Ikegami Y Sugimoto E Segi M Katsuyama H Karahashi F Amano, et al. 2001 The expression of prostaglandin E2 receptors EP2 and EP4 and their different regulation by lipopolysaccharide in C3H/HeN peritoneal macrophages The Journal of Immunology 166 7 4689 4696 11254729 1:CAS:528:DC%2BD3MXit1Oktbg%3D
137. C Voiculescu L Rosu S Rogoz 1988 Modulation of mouse spleen natural killer (NK) cell activity by beta-interferon, interleukin-1, and prostaglandins Lymphology 21 144 151 3264360 1:CAS:528:DyaL1MXjslGqtw%3D%3D
138. MJ Brunda RB Herberman HT Holden 1980 Inhibition of murine natural killer cell activity by prostaglandin The Journal of Immunology 124 6 2682 2687 6154736 1:CAS:528:DyaL3cXktlOqs7o%3D
139. A Bankhurst 1982 The modulation of human natural killer cell activity by prostaglandins Journal of Clinical & Laboratory Immunology 7 85 91 1:CAS:528:DyaL38Xhs1Slt78%3D
140. C Baxevanis G Reclos A Gritzapis G Dedousis I Missitzis M Papamichail 1993 Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer Cancer 72 2 491 501 8319179 1:STN:280: DyaK3szgs1Gqtw%3D%3D
141. A Fulton 1988 Inhibition of experimental metastasis with indomethacin: role of macrophages and natural killer cells Prostaglandins 35 3 413 425 3163812 1:CAS:528:DyaL1cXhvFOqtLs%3D
142. Y Su X Huang T Raskovalova L Zacharia A Lokshin E Jackson, et al. 2008 Cooperation of adenosine and prostaglandin E2 (PGE2) in amplification of cAMP-PKA signaling and immunosuppression Cancer Immunology and Immunotherapeutics 57 1611 1623 1:CAS:528:DC%2BD1cXhtVejsbjK
143. Y Su E Jackson E Gorelik 2011 Receptor desensitization and blockade of the suppressive effects of prostaglandin E2 and adenosine on the cytotoxic activity of human melanoma-infiltrating T lymphocytes Cancer Immunology and Immunotherapeutics 60 1 111 122 1:CAS:528:DC%2BC3MXht12gtr0%3D
144. Holt, D., Ma, X., Kundu, N., Fulton, A., (2011). Prostaglandin E2 (PGE2) suppresses natural killer cell function through the PGE2 receptor EP4. Cancer Immunology and Immunotherapy. doi: 10.1007/s00262-011-1064-9.
145. C Nataraj D Thomas S Tilley M Nguyen R Mannon B Koller, et al. 2001 Receptors for prostaglandin E2 that regulate cellular immune responses in the mouse The Journal of Clinical Investigation 108 8 1229 1235 11602631 1:CAS:528:DC%2BD3MXns1ChsLk%3D
146. C Yao D Sakata Y Esaki Y Li T Matsuoka K Kuroiwa, et al. 2009 Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion Nature Medicine 15 6 633 640 19465928 1:CAS:528:DC%2BD1MXmtlaku7o%3D
147. K Boniface K Bak-Jensen Y Li W Blumenschein M McGeachy T McClanahan, et al. 2009 Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling The Journal of Experimental Medicine 206 3 535 548 19273625 1:CAS:528:DC%2BD1MXjsVaisb4%3D
148. + T regulatory cell activities in lung cancer Cancer Research 65 12 5211 5220 15958566 1:CAS:528:DC%2BD2MXltFemurc%3D
149. E Fedyk R Phipps 1996 Prostaglandin E2 receptors of the EP2 and EP4 subtype regulate activation and differentiation of mouse B lymphocytes to IgE-secreting cells Proceedings of the National Academy of Sciences 93 10978 10983 1:CAS:528:DyaK28XmtVOksbk%3D
150. U Panzer M Uguccioni 2004 Prostaglandin E2 modulates the functional responsiveness of human monocytes to chemokines European Journal of Immunology 34 12 3682 3689 15484190 1:CAS:528:DC%2BD2cXhtFajtrvJ
151. G De Vries P Guarino A McLaughlin J Chen S Andrews D Woodward 1995 An EP receptor with a novel pharmacological profile in the T-cell line Jurkat British Journal of Pharmacology 115 1231 1234 7582550
152. E Fedyk J Ripper D Brown R Phipps 1996 A molecular analysis of PGE receptor (EP) expression on normal and transformed B lymphocytes: coexpression of EP1, EP2, EP3β, EP4 Molecular Immunology 33 1 33 45 8604222 1:CAS:528:DyaK28XhslKhs7s%3D
153. P Sinha VK Clements AM Fulton S Ostrand-Rosenberg 2007 Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells Cancer Research 67 9 4507 4513 17483367 1:CAS:528:DC%2BD2sXltVyrtrY%3D